The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Down syndrome (DS) is a genetic disorder caused by trisomy 21.
• DS invariably leads to altered brain development and intellectual disability.
• Synaptic deficits and memory impairment in DS are linked to GABAergic signaling alterations.

Purpose of the Study:

• To review GABAergic dysfunctions in the trisomic brain of DS mice and patients.
• To evaluate current clinical research targeting GABAergic signaling in individuals with DS.

Main Methods:

• Review of preclinical data from trisomic mouse models of DS.
• Analysis of studies on GABAergic neuron genesis, inhibitory drive, and network excitability.
• Assessment of pharmacological interventions targeting GABAergic signaling.

Main Results:

• Altered GABAergic signaling is a key factor in synaptic deficits and memory impairment in DS models.
• These alterations occur during development and persist into adulthood.
• Pharmacological targeting of GABAergic signaling has shown promise in preclinical studies.

Conclusions:

• GABAergic signaling is a complex and critical factor in Down syndrome brain development and cognitive function.
• Targeting GABAergic pathways represents a promising therapeutic strategy for cognitive impairment in DS.